Page last updated: 2024-08-23

epirubicin and Infusion Site Adverse Event

epirubicin has been researched along with Infusion Site Adverse Event in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borley, A; Dolan, G; Hanna, L; Roberts, R; Williams, EM1

Other Studies

1 other study(ies) available for epirubicin and Infusion Site Adverse Event

ArticleYear
Epirubicin chemotherapy in women with breast cancer: Alternating arms for intravenous administration to reduce chemical phlebitis.
    European journal of cancer care, 2019, Volume: 28, Issue:5

    Topics: Administration, Intravenous; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Injection Site Reaction; Middle Aged; Phlebitis; Prospective Studies

2019
chemdatabank.com